Under Armour Inc Class A vs UnitedHealth Group Inc — how do they compare? Under Armour Inc Class A trades at $4.78 (market cap $2.07B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 160.9× Under Armour Inc Class A's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals — on Pluang, investors hold Under Armour Inc Class A for 18 Days and UnitedHealth Group Inc for 97 Days on average.
| UA | UNH | |
|---|---|---|
Market Cap | $2.07B | $332.96B |
Volume | 2,680,141 | 7,273,749 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.88 | $436.35 |
52-Week Low | $3.96 | $259.02 |
Typical Hold Time | 18 Days | 97 Days |
Enterprise Value | $3.05B | $374.82B |
Dividend Yield | — | 2.5% |
Signals from Pluang's Aura AI — not financial advice
Under Armour (UA) trades at $4.74, up 0.85% with a bullish technical signal despite mixed earnings. The company faces revenue declines and negative profitability with a -9.99% net margin, though valuation metrics like P/S of 0.41 appear attractive. Recent Q2 2026 earnings beat expectations, but guidance has been lowered amid softer consumer demand.
Outlook remains challenging with significant cash burn and competitive pressures. While analyst sentiment is mixed with 39.7% buy ratings, the stock offers speculative value for turnaround investors willing to bear execution risks and ongoing revenue headwinds in the athletic apparel sector.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →